Chris Mirabile

Founder & CEO of NOVOS, the first human longevity company to simultaneously address the 12 Mechanisms of Aging (biological causes of aging) through its scientifically-validated, patent pending, over-the-counter formulations; best-in-class biological age tests; and free AI tools.

NOVOS is a Public Benefit Corporation that strives to make human longevity accessible and achievable for all.

NOVOS is composed of Scientific & Medical Advisory Boards and an R&D team of world renowned scientists and MDs who study aging from Harvard, MIT, and other esteemed institutions, such as the inventor of the first gene sequencing method, Dr. George Church, longevity scientist Dr. Matt Kaeberlein, and more. Learn more at novoslabs.com.